Publications 2022

Simon C, Stielow B, Nist A, Rohner I, Weber LM, Geller M, Fischer S, Stiewe T, Liefke R. The CpG Island-Binding Protein SAMD1 Contributes to an Unfavorable Gene Signature in HepG2 Hepatocellular Carcinoma Cells. Biology 2022, 11, 557. DOI: 10.3390/biology11040557

Schmitz ML, Dreute J, Pfisterer M, Günther S, Kracht M, Chillappagari S. SIAH ubiquitin E3 ligases as modulators of inflammatory gene expression. Heliyon 2022 Mar 1;8(3):e09029. DOI: 10.1016/j.heliyon.2022.e09029

Klimovich B, Meyer L, Merle N, Neumann M, König AM, Ananikidis N, Keber CU, Elmshäuser S, Timofeev O, Stiewe T. Partial p53 reactivation is sufficient to induce cancer regression. J Exp Clin Cancer Res 2022 Mar 2;41(1):80. DOI: 10.1186/s13046-022-02269-6

Klimovich B, Merle N, Neumann M, Elmshäuser S, Nist A, Mernberger M, Kazdal D, Stenzinger A, Timofeev O, Stiewe T. p53 partial loss-of-function mutations sensitize to chemotherapy. Oncogene 2022 Feb;41(7):1011-1023. DOI: 10.1038/s41388-021-02141-5

Priester J, Dreute J, Kracht M, Schmitz ML. Post-Transcriptional Control of mRNA Metabolism and Protein Secretion: The Third Level of Regulation within the NF-κB System. Biomedicines 2022, 10, 2108. DOI: 10.3390/biomedicines10092108

Preußer C, Stelter K, Tertel T, Linder M, Helmprobst F, Szymanski W, Graumann J, Giebel B, Reinartz S, Müller R, Weber G, & Pogge von Strandmann E. Isolation of native EVs from primary biofluids—Free-flow electrophoresis as a novel approach to purify ascites-derived EVs. Journal of Extracellular Biology, 1, e71. doi: 10.1002/jex2.71